Suppr超能文献

成年骨肉瘤患者的I型和III型胶原代谢产物

Type I and type III collagen metabolites in adult osteosarcoma patients.

作者信息

Wiklund T, Blomqvist C, Risteli L, Risteli J, Karaharju E, Elomaa I

机构信息

Department of Radiotherapy and Oncology, University of Helsinki, Finland.

出版信息

Br J Cancer. 1996 Jan;73(1):106-9. doi: 10.1038/bjc.1996.19.

Abstract

Three biochemical markers of collagen metabolism were measured in 39 osteosarcoma patients. The pretreatment values did not predict outcome, and the markers showed no consistent change upon development of metastases. Both the age of the patients and the multimodality therapy affected the collagen metabolites. These findings emphasise the need for cautious interpretation of tumour-associated markers.

摘要

在39例骨肉瘤患者中测量了三种胶原代谢的生化标志物。治疗前的值不能预测预后,并且这些标志物在发生转移时没有表现出一致的变化。患者的年龄和多模式治疗都影响了胶原代谢产物。这些发现强调了对肿瘤相关标志物进行谨慎解读的必要性。

相似文献

3
[Biochemical bone resorption markers in children with osteosarcoma].
Med Wieku Rozwoj. 2004 Apr-Jun;8(2 Pt 1):225-33.
7
Biochemical markers of bone turnover.骨转换的生化标志物
Horm Res. 1996;45 Suppl 1:55-8. doi: 10.1159/000184832.

本文引用的文献

2
Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.
Cancer. 1993 Feb 15;71(4):1224-30. doi: 10.1002/1097-0142(19930215)71:4<1224::aid-cncr2820710409>3.0.co;2-m.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验